Literature DB >> 31211001

Reliability of Semiautomated Kinetic Perimetry (SKP) and Goldmann Kinetic Perimetry in Children and Adults With Retinal Dystrophies.

Claire S Barnes1, Ronald A Schuchard2, David G Birch3, Gislin Dagnelie4, Leah Wood5, Robert K Koenekoop6, Ava K Bittner4,7,8.   

Abstract

PURPOSE: To investigate the precision of visual fields (VFs) from semiautomated kinetic perimetry (SKP) on Octopus 900 perimeters, for children and adults with inherited retinal degenerations (IRDs). Goldmann manual kinetic perimetry has long been used in the diagnosis and follow-up of these patients, but SKP is becoming increasingly common. Octopus VFs (OVFs) and Goldmann VFs (GVFs) were both mapped on two occasions.
METHODS: Nineteen females and 10 males with IRDs were tested on OVFs and GVFs, with two targets per test (V4e and one smaller target). Tests were performed in the same (randomized) order at two visits about 1 week apart. The VFs were digitized to derive isopter solid angles. Comparisons, within and between visits, were performed with paired t-tests and Bland-Altman plots.
RESULTS: Median age was 20 years (range, 7-70; 10 participants aged ≤17 years old). There were no significant differences in solid angles between OVFs and GVFs (P ≥ 0.06) or between the two visits' solid angles on either perimeter (P ≥ 0.30). Between-visit test-retest variability for GVFs and OVFs was similar (P ≥ 0.73), with median values of approximately 9% to 13%. Overall variability was lower for children than adults (medians of 7.5% and 12.8%, respectively).
CONCLUSIONS: Octopus SKP and Goldmann perimetry produced VFs of similar size and variability. TRANSLATIONAL RELEVANCE: Our study indicates that SKP provides a viable alternative to traditional Goldmann perimetry in clinical trials or care involving both children and adults with IRDs.

Entities:  

Keywords:  Goldmann perimetry; Leber congenital amaurosis; children; retinitis pigmentosa; semiautomated kinetic perimetry (SKP); test–retest variability

Year:  2019        PMID: 31211001      PMCID: PMC6561130          DOI: 10.1167/tvst.8.3.36

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


  30 in total

1.  Scotoma mapping by semi-automated kinetic perimetry: the effects of stimulus properties and the speed of subjects' responses.

Authors:  Jan Dolderer; Reinhard Vonthein; Chris A Johnson; Ulrich Schiefer; William Hart
Journal:  Acta Ophthalmol Scand       Date:  2006-06

2.  Automated combined kinetic and static perimetry: an alternative to standard perimetry in patients with neuro-ophthalmic disease and glaucoma.

Authors:  Stacy L Pineles; Nicholas J Volpe; Eydie Miller-Ellis; Steven L Galetta; Prithvi S Sankar; Kenneth S Shindler; Maureen G Maguire
Journal:  Arch Ophthalmol       Date:  2006-03

3.  Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.

Authors:  Ava K Bittner; Mian Haris Iftikhar; Gislin Dagnelie
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

4.  Comparison between semiautomated kinetic perimetry and conventional Goldmann manual kinetic perimetry in advanced visual field loss.

Authors:  Katarzyna Nowomiejska; Reinhard Vonthein; Jens Paetzold; Zbigniew Zagorski; Randy Kardon; Ulrich Schiefer
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

5.  Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test.

Authors:  Kilian Schulze-Bonsel; Nicolas Feltgen; Hermann Burau; Lutz Hansen; Michael Bach
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

6.  Feasibility and outcome of automated kinetic perimetry in children.

Authors:  Stephanie Wilscher; Bettina Wabbels; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-16       Impact factor: 3.117

7.  The normal age-corrected and reaction time-corrected isopter derived by semi-automated kinetic perimetry.

Authors:  Reinhard Vonthein; Stephan Rauscher; Jens Paetzold; Katarzyna Nowomiejska; Elke Krapp; Agnes Hermann; Bettina Sadowski; Céline Chaumette; John M Wild; Ulrich Schiefer
Journal:  Ophthalmology       Date:  2007-02-28       Impact factor: 12.079

8.  The use of semi-automated kinetic perimetry (SKP) to monitor advanced glaucomatous visual field loss.

Authors:  J Nevalainen; J Paetzold; E Krapp; R Vonthein; C A Johnson; U Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-18       Impact factor: 3.117

9.  A comparison of semiautomated versus manual Goldmann kinetic perimetry in patients with visually significant glaucoma.

Authors:  Adriana M Ramirez; Craig J Chaya; Lynn K Gordon; Joann A Giaconi
Journal:  J Glaucoma       Date:  2008-03       Impact factor: 2.503

10.  Reaction time during semi-automated kinetic perimetry (SKP) in patients with advanced visual field loss.

Authors:  Katarzyna Nowomiejska; Reinhard Vonthein; Jens Paetzold; Zbigniew Zagorski; Randy Kardon; Ulrich Schiefer
Journal:  Acta Ophthalmol       Date:  2009-12-16       Impact factor: 3.761

View more
  3 in total

1.  Characterizing Visual Fields in RPGR Related Retinitis Pigmentosa Using Octopus Static-Automated Perimetry.

Authors:  Thomas M W Buckley; Amandeep Singh Josan; Laura J Taylor; Jasleen K Jolly; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

2.  Monitoring progression of retinitis pigmentosa: current recommendations and recent advances.

Authors:  Moreno Menghini; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Expert Opin Orphan Drugs       Date:  2020-03-02       Impact factor: 0.694

3.  RPGR-Associated Dystrophies: Clinical, Genetic, and Histopathological Features.

Authors:  Xuan-Thanh-An Nguyen; Mays Talib; Mary J van Schooneveld; Joost Brinks; Jacoline Ten Brink; Ralph J Florijn; Jan Wijnholds; Robert M Verdijk; Arthur A Bergen; Camiel J F Boon
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.